These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21125268)

  • 1. Reproducibility study of [(18)F]FPP(RGD)2 uptake in murine models of human tumor xenografts.
    Chang E; Liu S; Gowrishankar G; Yaghoubi S; Wedgeworth JP; Chin F; Berndorff D; Gekeler V; Gambhir SS; Cheng Z
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):722-30. PubMed ID: 21125268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice.
    Tseng JR; Dandekar M; Subbarayan M; Cheng Z; Park JM; Louie S; Gambhir SS
    J Nucl Med; 2005 Nov; 46(11):1851-7. PubMed ID: 16269599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of 18F-FDG microPET studies in mouse tumor xenografts.
    Dandekar M; Tseng JR; Gambhir SS
    J Nucl Med; 2007 Apr; 48(4):602-7. PubMed ID: 17401098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides.
    Jacobson O; Zhu L; Niu G; Weiss ID; Szajek LP; Ma Y; Sun X; Yan Y; Kiesewetter DO; Liu S; Chen X
    Mol Imaging Biol; 2011 Dec; 13(6):1224-33. PubMed ID: 21161690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
    Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
    J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers.
    Liu Z; Liu S; Wang F; Liu S; Chen X
    Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1296-307. PubMed ID: 19296102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.
    Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC
    J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First experience with clinical-grade ([18F]FPP(RGD₂): an automated multi-step radiosynthesis for clinical PET studies.
    Chin FT; Shen B; Liu S; Berganos RA; Chang E; Mittra E; Chen X; Gambhir SS
    Mol Imaging Biol; 2012 Feb; 14(1):88-95. PubMed ID: 21400112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature.
    Cai W; Chen K; Li ZB; Gambhir SS; Chen X
    J Nucl Med; 2007 Nov; 48(11):1862-70. PubMed ID: 17942800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis and parametric imaging of 18F-labeled monomeric and dimeric RGD peptides using compartment model.
    Guo N; Lang L; Gao H; Niu G; Kiesewetter DO; Xie Q; Chen X
    Mol Imaging Biol; 2012 Dec; 14(6):743-52. PubMed ID: 22437879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6.
    Hackel BJ; Kimura RH; Miao Z; Liu H; Sathirachinda A; Cheng Z; Chin FT; Gambhir SS
    J Nucl Med; 2013 Jul; 54(7):1101-5. PubMed ID: 23670900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-FPPRGD2 PET/CT: pilot phase evaluation of breast cancer patients.
    Iagaru A; Mosci C; Shen B; Chin FT; Mittra E; Telli ML; Gambhir SS
    Radiology; 2014 Nov; 273(2):549-59. PubMed ID: 25033190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of PET Imaging for Prognostic Integrin α
    Huang CW; Hsieh WC; Hsu ST; Lin YW; Chung YH; Chang WC; Chiu H; Lin YH; Wu CP; Yen TC; Huang FT
    Theranostics; 2017; 7(16):4013-4028. PubMed ID: 29109795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syntheses and Preliminary Evaluation of Dual Target PET Probe [18F]-NOTA-Gly3- E (2PEG4-RGD-WH701) for PET Imaging of Breast Cancer.
    Chen Z; Fu H; Wu H; Huang J; Yao L; Zhang X; Li Y
    Anticancer Agents Med Chem; 2020; 20(13):1548-1557. PubMed ID: 32329699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of
    Hiroyama S; Matsunaga K; Ito M; Iimori H; Tajiri M; Nakano Y; Shimosegawa E; Abe K
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4358-4368. PubMed ID: 35876866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging.
    Liu Z; Niu G; Shi J; Liu S; Wang F; Liu S; Chen X
    Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):947-57. PubMed ID: 19159928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.
    Liu Z; Yan Y; Liu S; Wang F; Chen X
    Bioconjug Chem; 2009 May; 20(5):1016-25. PubMed ID: 20540537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression.
    Liu S; Liu Z; Chen K; Yan Y; Watzlowik P; Wester HJ; Chin FT; Chen X
    Mol Imaging Biol; 2010 Oct; 12(5):530-8. PubMed ID: 19949981
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Wang Y; Liu H; Yao D; Li J; Yang S; Zhang C; Chen W; Wang D
    J Nanobiotechnology; 2019 Oct; 17(1):105. PubMed ID: 31604441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.